CBCT in Guiding Bronchoscopy in Patients With Lung Lesions (NCT02978170) | Clinical Trial Compass
CompletedNot Applicable
CBCT in Guiding Bronchoscopy in Patients With Lung Lesions
United States21 participantsStarted 2016-11-28
Plain-language summary
This pilot clinical trial studies how well cone-beam computed tomography (CBCT) works in guiding bronchoscopy in patients with lung lesions. CBCT during bronchoscopy may help doctors to biopsy lung lesions that are harder to reach.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients undergoing guided-bronchoscopy for diagnosis of peripheral lung lesion/s \> 1 and \< 3 cm in diameter located in the outer 2/3 of the lung fields
Exclusion Criteria:
* Pregnant or breastfeeding women
* Patient with indications for mediastinal lymph node (LN) sampling per 13th American College of Clinical Pharmacy (ACCP) guidelines
* Patient with metastatic disease (from primaries other than lung) who have suspicious mediastinal or hilar LN that require sampling
* Patients with contraindication/s for general anesthesia (e.g., severe and active coronary artery disease, chronic obstructive pulmonary disease \[COPD\] with forced expiratory volume in 1 second \[FEV1\] \< 1 liter, uncontrolled hypertension, increased intracranial pressure, history of intolerance to general anesthesia)
* Dementia or other severe cognitive impairment causing inability to understand or consent to the procedure and study
What they're measuring
1
Feasibility based on percentage of patients where researchers can locate target and bronchoscopic tools with cone-beam computed tomography